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Day to Day and Leg to Leg Variation in Gene Expression 
BACKGROUND: Skeletal muscle biopsies are extensively used in
research to determine the effects of exercise. Usually, sequential
biopsies are taken before and after exercise in order to determine the
influence of exercise on gene expression. Often it is not clear if the
results are due to exercise or as a result of damage cause by the biopsy
to the muscle. Previous studies have proven that multiple biopsies in the
same leg cause stress to the muscle and such stress leads to
inflammation and other response pathways that alter the gene
expression. PURPOSE: The purpose of this study is to determine the
day to day variance in skeletal muscle gene expression in the same leg
and between legs to establish an experimental design that eliminates
artifacts and reduces the number of biopsies needed for a study.
METHODS: Eight participants had a muscle biopsy taken from the
vastus lateralis muscle on three separate occasions approximately 1
week apart after repeating the same diet and exercise for 24 hours prior.
Legs were randomized and altered on subsequent weeks. Genes related
to mitochondrial development and stable reference were measured using
real-time PCR. The first biopsy was defined as stable reference control
condition and gene expression was normalized using 2-∆∆CT and 2-∆CT
method. Results: No difference was found in gene expression from day
to day variation or between legs for ERRa (p = 0.85), GABPA (P =
0.85), MEF2a (P = 0.86), NRF1 (P = 0.97), PPARG (P = 0.38), PGC1a
(p = 0.88), SIRT1 (p = 0.299), TFAM (p = 0.99), and VEGF (p = 0.61).
For FNDC5 there was a difference between legs, trial 1 compared to
trial 2 (p = 0.04), but trial 2 compared to trial 3 did not show a
difference (p = 0.906) and not within the same leg trial 1 to trial 3 (p =
0.946). The reference genes B2M (p = 0.005) and CYC (p = 0.002) were
different between biopsies; GAPDH and RPS18 were not different
between biopsies (p > 0.05). Conclusion: While many genes are
statistically not different between legs and between days, researchers
need to determine the amount of error that is acceptable in each study
design.
Zohal Alizai, Robert Shute, Dustin Slivka
University of Nebraska at Omaha, School of Health and Kinesiology, Omaha, NE
ABSTRACT
FUNDING
RESULTS  
METHODS RESULTS 
Exercise Physiology Lab
• Genes related to mitochondrial biogenesis are not statistically
different between legs or between days except for FNDC5 which
was different between biopsy 1 and 2 but not different than biopsy
3.
• Two of the four stable reference genes were stable between
biopsies and two were higher on biopsy 3 than the other biopsies.
However, by using the geometric mean of all four reference genes
these differences disappear.
• While many genes are statistically not different between legs and
between days, researchers need to determine the amount of error
that is acceptable in each study design.
• 12 more subjects are currently being analyzed to expand the sample
size.
• These data will aid researchers utilizing the muscle biopsy
technique in the best study design in terms of the appropriate
timing of the biopsy in relation to subsequent biopsies.
CONCLUSION AND FUTURE DIRECTION 
This work was supported by the National Institute for General
Medical Science (NIGMS P20GM103427), Nebraska IDeA
Networks of Biomedical Research Excellence (INBRE)
Eight healthy college age volunteers had a muscle biopsy taken from the
vastus lateralis on three separate occasions separated by 7 days. Before
the biopsies were taken, all the subjects were instructed to not exercise
and keep the same diet one day prior to the biopsy. Two biopsies were
taken from one leg and a third biopsy was taken from the other. This will
allow comparisons between and within legs on different days. A total of
24 muscle biopsies were analyzed to test the expression of genes using
real time PCR. Genes related to mitochondrial development were ERRa,
GABPA , MEF2a, NRF1, PPARG, PGC1a, SIRT1, TFAM, VEGF, and
FNDC5 and stable reference genes B2M, CYC, GAPDH and RPS18.
Gene expression was expressed using the 2-∆∆CT and 2-∆CT method. The
stable reference control condition for 2-∆∆CT was defined as the first
biopsy. A one-way repeated measures analysis of variance (ANOVA)
was used to determine statistical significance. All data is presented as
mean ± standard error.
Figure 2: Day To Day Variance In Stable Reference Gene Expression
Between Legs and Within Legs were Significant For B2M and CYC.
Gene expression was utilized using the 2-∆∆CT method. The stable reference
control condition was defined as the first biopsy. Biopsy 3 had higher
expression than biopsies 1 and 2 for B2M and CYC (p < 0.05). GAPDH and
RPS18 were not different between biopsies (p > 0.05). *p < 0.05 from biopsies
1 and 2. Values are mean ± SE in relative units.
Figure 1: Day To Day Variance In Genes Related To Mitochondrial Development
Showed No Significance Except FNDC5. Gene expression was utilized using the 2-
∆CT method for Figure 1A and 2-∆∆CT for Figure 1B. The stable reference control
condition was defined as the first biopsy. No difference was found in gene expression
from day to day variation or between legs for ERRa, GABPA, MEF2a, NRF1, PPARG,
PGC1a, SIRT1, TFAM, and VEGF (p > 0.05). FNDC5 was different between legs
(biopsy 1 compared to biopsy 2; p=0.04), but biopsy 3 was similar to biopsies 1 and 2
(p > 0.05). * p < 0.05 from biopsy 1. Values are mean ± SE in relative units.
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The purpose of this study is to
determine the day to day variance in
skeletal muscle gene expression in the
same leg and between legs to establish
an experimental design that eliminates
artifacts and reduces the number of
biopsies needed for a study.
